Monday, January 19, 2026 | 12:11 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 12 - Biocon

Stocks to Watch Today: Adani Power, Biocon, Tata Steel, NTPC, PSU Banks

Stocks to Watch Today: Among airline shares, SpiceJet has reported seven aircraft related incidents in the last two months; while IndiGo said has hired over 1,500 cabin crew staff to counter likely at

Stocks to Watch Today: Adani Power, Biocon, Tata Steel, NTPC, PSU Banks
Updated On : 06 Jul 2022 | 7:31 AM IST

Delhi HC rejects CBI plea for custody of four accused in Biocon case

The high court, however, directed the jail superintendent to hand over the custody of associate vice president of Biocon Biologics L Praveen Kumar

Delhi HC rejects CBI plea for custody of four accused in Biocon case
Updated On : 06 Jul 2022 | 2:14 AM IST

Research-linked incentive scheme in works for pharmaceutical industry

15% turnover investment in research could make companies eligible for the scheme

Research-linked incentive scheme in works for pharmaceutical industry
Updated On : 04 Jul 2022 | 1:38 AM IST

Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven

The company has entered into an agreement for the purpose of "acquisition of solar power by acquiring equity stake up to 26 per cent in AREREPL", it said.

Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven
Updated On : 29 Jun 2022 | 9:37 PM IST

Stocks to watch: Reliance, Tata Motors, Biocon, Tata Steel, J&K Bank, BoB

Stocks to watch today: Akash M Ambani will take over as non-executive director and chairman of the board of directors of Reliance Jio; Tata Motors will hike prices of CVs by 1.5 to 2.5 per cent.

Stocks to watch: Reliance, Tata Motors, Biocon, Tata Steel, J&K Bank, BoB
Updated On : 29 Jun 2022 | 7:53 AM IST

Biocon bribery case: CBI moves Delhi HC for custody of accused officials

CBI on Tuesday moved the Delhi High Court seeking the custody of officials accused of allegedly demanding bribes to waive the Phase-3 trial of "Insulin Aspart Injection"

Biocon bribery case: CBI moves Delhi HC for custody of accused officials
Updated On : 29 Jun 2022 | 7:24 AM IST

Biocon Biologics bribery case: CBI moves HC challenging lower court verdict

The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2

Biocon Biologics bribery case: CBI moves HC challenging lower court verdict
Updated On : 28 Jun 2022 | 7:55 PM IST

Stocks to watch: Adani Enterprises, Dish TV, Infosys, Hindustan Copper

Stocks to watch today: Adani Enterprises subsidiary raised over Rs 6,000 crore to set up greenfield copper refinery; State-run IOB will boost advances across retail, corporate and MSME loans this year

Stocks to watch: Adani Enterprises, Dish TV, Infosys, Hindustan Copper
Updated On : 27 Jun 2022 | 8:02 AM IST

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
Updated On : 22 Jun 2022 | 2:31 AM IST

SEC recommendation in accordance with guidelines: Biocon Biologics

The company said its product approvals are backed by science and clinical data

SEC recommendation in accordance with guidelines: Biocon Biologics
Updated On : 22 Jun 2022 | 1:15 AM IST

Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others.

Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
Updated On : 20 Jun 2022 | 10:58 PM IST

Biocon hits over two-year low; slips 18% in six weeks post weak Q4 results

In the past one year, the stock has slipped 22 per cent, as against a 39 per cent rally in the S&P BSE Sensex.

Biocon hits over two-year low; slips 18% in six weeks post weak Q4 results
Updated On : 08 Jun 2022 | 11:55 AM IST

CCI approves Serum Institute Life Sciences-Biocon Biologics deal

The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to the notice filed with the regulator. Covidshield Technologies Pvt Ltd (CTPL), a wholly-owned subsidiary of Serum Institute of Life Sciences, will be merged into Biocon Biologics. In a tweet on Wednesday, the watchdog said it has cleared the "merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15 per cent equity shareholding of Biocon Biologics by Serum Institute Life Sciences." CTPL was incorporated to undertake the business of marketing, selling and distributing vaccines, drugs and other pharmaceutical products. Biocon Biologics Ltd is a subsidiary of Biocon Ltd. It offers treatment for chronic and acute diseases such as

CCI approves Serum Institute Life Sciences-Biocon Biologics deal
Updated On : 19 May 2022 | 5:59 PM IST

Stocks to Watch: ITC, Lupin, Ruchi Soya, Manappuram Finance, JSW, Biocon

Stocks to Watch: The US markets suffered the biggest one-day sell-off in almost two years -Investors worry about inflation and its impact on earnings and prospects for monetary policy tightening

Stocks to Watch: ITC, Lupin, Ruchi Soya, Manappuram Finance, JSW, Biocon
Updated On : 19 May 2022 | 8:27 AM IST

Ireland regulator reports manufacturing deficiency at Biocon's plant

Biocon Biologics is a subsidiary of Biocon Ltd

Ireland regulator reports manufacturing deficiency at Biocon's plant
Updated On : 04 May 2022 | 1:59 AM IST

BJP hits out at Kiran Shaw for keeping mum on students carrying Bibles

The BJP used the signing of MoU for setting up the largest semiconductor fabrication unit in Karnataka to hit out at Shaw

BJP hits out at Kiran Shaw for keeping mum on students carrying Bibles
Updated On : 02 May 2022 | 12:47 PM IST

Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore

Biocon's consolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period

Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore
Updated On : 28 Apr 2022 | 10:53 PM IST

F&O expiry: Nifty ends April series above 17,200; Sensex gains 702 pts

As of 06:50 AM, the SGX Nifty April futures quoted at 17,066. According to analysts, the April series has been one of the most volatile series for the Nifty in recent times. The options data.

F&O expiry: Nifty ends April series above 17,200; Sensex gains 702 pts
Updated On : 28 Apr 2022 | 3:34 PM IST

BJP accuses Biocon chief of imposing personal, politically coloured opinion

The BJP accused her of imposing personal and 'politically coloured' opinion and conflating it with India's leadership in Information technology and biotechnology sectors

BJP accuses Biocon chief of imposing personal, politically coloured opinion
Updated On : 31 Mar 2022 | 4:14 PM IST

Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow

Mazumdar-Shaw, who is also the Executive Chairperson of Biocon Biologics, will be joining RSE's current fellowship of around 1,700 fellows, the company said in a statement

Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
Updated On : 23 Mar 2022 | 6:47 PM IST